Pantoprazole Prophylaxis Against Delayed CINV for Patients Receiving Breast Cancer Chemotherapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Oncology|Breast Cancer|Chemotherapy-induced Nausea and Vomiting
Interventions: DRUG: Pantoprazole 40mg|DRUG: Placebo
Sponsor: University of Auckland, New Zealand